Abstract
Discovery of comorbidities (the concomitant occurrence of distinct medical conditions in the same patient) is a prerequisite for creating forecasting tools for downstream outcomes research. Current comorbidity discovery applications are designed for small datasets and use stratification to control for confounding variables such as age, sex, or ancestry. Stratification lowers false positive rates, but reduces power, as the size of the study cohort is decreased. Here, we describe a Poisson Binomial based approach to comorbidity discovery (PBC) designed for big-data applications that circumvents the need for stratification. PBC adjusts for confounding demographic variables on a per-patient basis, and models temporal relationships. We benchmark PBC using two datasets, the publicly available MIMIC-IV; and the entire Electronic Health Record (EHR) corpus of the University of Utah Hospital System, encompassing over 1.6 million patients, to compute comorbidity statistics on 4,623,841 pairs of potentially comorbid medical terms. The results of this computation are provided as a searchable web resource. Compared to current methods, the PBC approach reduces false positive associations, while retaining statistical power to discover true comorbidities.
Competing Interest Statement
Gordon Lemmon and Mark Yandell and own shares in Backdrop Health, a University of Utah effort to commercialize Bayesian inference on health records. However, there are no financial ties regarding this research.
Funding Statement
The computational resources used were partially funded by the NIH Shared Instrumentation Grant 1S10OD021644-01A1. This research was supported by the AHA Children's Strategically Focused Research Network grant (17SFRN33630041) and the Nora Eccles Treadwell Foundation. Gordon Lemmon was supported by NRSA training grant T32H757632. Sergiusz Wesolowski was supported by NRSA training grant T32DK110966-04 and the AHA Children's Strategically Focused Research Network Fellowship award (17SFRN33630041).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Utah Institutional Review Board IRB_00136167EXEMPTION UMBRELLA: Assembling de-identified machine learning datasets for outcomes research.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
In this paper we calculate comorbidity statistics for all pairs of medical billing codes - including diagnoses, procedures, and medications. All of these p-values are available to query and download from the following link: https://pbc.genetics.utah.edu/lemmon2021
